000			01323 a2200397 4500
005			20250515181655.0
264		0	_c20100421
008			201004s 0 0 eng d
022			_a1720-8386
024	7		_a10.1007/BF03345777 _2doi
040			_aNLM _beng _cNLM
100	1		_aPiñar, D
245	0	0	_aSunitinib-induced thyrotoxicosis. _h[electronic resource]
260			_bJournal of endocrinological investigation _cDec 2009
300			_a941-2 p. _bdigital
500			_aPublication Type: Case Reports; Letter
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCarbimazole _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIndoles _xadverse effects
650	0	4	_aKidney Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aPropranolol _xtherapeutic use
650	0	4	_aPyrroles _xadverse effects
650	0	4	_aSunitinib
650	0	4	_aThyroid Hormones _xblood
650	0	4	_aThyrotoxicosis _xchemically induced
700	1		_aBoix, E
700	1		_aMeana, J A
700	1		_aHerrero, J
773	0		_tJournal of endocrinological investigation _gvol. 32 _gno. 11 _gp. 941-2
856	4	0	_uhttps://doi.org/10.1007/BF03345777 _zAvailable from publisher's website
999			_c19044337 _d19044337